Clinical Trials Directory

Trials / Completed

CompletedNCT06074172

The Effect of Cannabidiol in Learning and Memory of Adults

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Colorado State University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The main objectives of this study were to test if a singular dose of Cannabidiol (1) enhances the learning and memory of healthy human subjects, (2) test if Cannabidiol has negative effects on Retroactive and Proactive Interference during learning, (3) and test if demographic factors will influence CBD's modulation of human learning and memory.

Detailed description

Using a randomized, double-blind, placebo-controlled two-arm case-crossover trial, this study investigates the effect of 246 milligrams (mg) of Cannabidiol (CBD) on the learning and memory scores of human subjects, as well as the effect of Cannabidiol on Proactive and Retroactive Interference. This study also investigated the influence of demographic factors on CBD's modulation of human learning and memory. This study was conducted at Colorado State University-Pueblo (CSU Pueblo) with volunteers recruited from CSU Pueblo and the local Pueblo community. Fifty-seven subjects were randomized in a double-blind manner to receive either CBD or placebo before completing two versions of learning and memory assessments. Each version of the learning and memory assessment included the Montreal Cognitive Assessment (MOCA), the Rey Auditory Verbal Learning Task-Revised (RAVLT-R), and the Logical Memory Subject of the Weschler Memory Scale. Several components of the RAVLT-R were evaluated including the Sum of Trials (Trials I-V) score, Proactive Interference Ratio (PI Ratio), and Retroactive Interference (RI Ratio).

Conditions

Interventions

TypeNameDescription
DRUGCannabidiol (246mg press pill)Cannabidiol press pills provided by Steve Goods CBD (Longmont, Colorado). CBD pills were tested by the chemistry lab at CSU Pueblo and by Botanacor in Denver, CO. Both laboratories determined CBD pills to be 99.98% pure with no THC, heavy metals, bacteria, and pesticides detected.
DRUGPlacebo (246mg press pill)Placebo press pills were provided by Steve Goods CBD (Longmont, Colorado). Placebo pills were tested by the chemistry lab at CSU Pueblo and by Botanacar in Denver, CO. Both laboratories determined placebo pills to be pure with no heavy metals, bacteria, and pesticides detected.

Timeline

Start date
2020-03-14
Primary completion
2020-11-06
Completion
2020-11-06
First posted
2023-10-10
Last updated
2025-03-24
Results posted
2025-03-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06074172. Inclusion in this directory is not an endorsement.